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DNA methylation is a hallmark of transcriptional silencing, yet transcription has been reported at the centromere. To
address this apparent paradox, we employed a fully sequence-defined ectopic human centromere (or neocentromere)
to investigate the relationship between DNA methylation and transcription. We used sodium bisulfite PCR and
sequencing to determine the methylation status of 2,041 CpG dinucleotides distributed across a 6.76-Mbp
chromosomal region containing a neocentromere. These CpG dinucleotides were associated with conventional and
nonconventional CpG islands. We found an overall hypermethylation of the neocentric DNA at nonconventional CpG
islands that we designated as CpG islets and CpG orphans. The observed hypermethylation was consistent with the
presence of a presumed transcriptionally silent chromatin state at the neocentromere. Within this neocentric
chromatin, specific sites of active transcription and the centromeric chromatin boundary are defined by DNA
hypomethylation. Our data demonstrate, for the first time to our knowledge, a correlation between DNA methylation
and centromere formation in mammals, and that transcription and ‘‘chromatin-boundary activity’’ are permissible at
the centromere through the selective hypomethylation of pockets of sequences without compromising the overall
silent chromatin state and function of the centromere.
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Introduction
Centromeres are essential for the proper segregation of
replicated chromosomes in eukaryotes. Recent studies have
identiﬁed a plethora of conserved centromeric proteins [1,2].
Some of these proteins provide the foundation for the
assembly and maintenance of a constitutive kinetochore,
while others transiently associate with the centromere to
confer speciﬁc roles such as sister chromatid cohesion, mitotic
checkpoint function, and chromatid motor activity [3,4]. In
addition, an increasing number of chromatin-modiﬁcation
proteins have been detected at the centromere and its
surrounding heterochromatin [4–6]. Unlike the conservation
of proteins at the centromere, centromeric DNA is highly
divergent across species, suggesting an epigenetic inﬂuence
on centromere identity and function [7–9].
DNA methylation is an important epigenetic marker that
acts through the covalent addition of a methyl moiety to the
cytosine residue of a CpG dinucleotide by the DNA
methyltransferase (DNMT) family of proteins [10]. In humans,
a CpG dinucleotide occurs at 5-fold less than the expected
frequency [11]. It has been shown that the decrease in
observed CpG frequency is complemented by an equal
increase in observed TpG frequency, in part owing to the
hypermutability of methylated cytosines to thymine [12,13].
However, there are pockets within the genome where the
observed CpG frequency reaches the expected levels—
suggesting that these regions may have a biological function.
These regions are deﬁned as CpG islands [14,15].
It has been estimated that up to 80% of all CpG
dinucleotides in mammals are methylated [16]. CpG dinu-
cleotides within CpG islands are more often than not
unmethylated. The classical deﬁnition of these islands has
been for sequences greater than 200 bp in length, with a GC
content greater than 50% and an observed-to-expected GpC
ratio of greater than or equal to 0.6 [15]. CpG islands are
present in the promoter regions of approximately 40% of the
genes in the mammalian genome [17,18]. Methylation of these
CpG islands is thought to play a direct role in the control of
gene transcription, genomic imprinting [19], X-chromosome
inactivation [20], and in tumorigenesis [21].
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include sequences greater than 500 bp in length, with a GC
content greater than 55% and an observed-to-expected GC
ratio greater than 0.65 [22]. These stringent measures enable
the identiﬁcation of functional CpG islands associated with
the promoter region of genes and the exclusion of all
parasitic GC-rich repetitive elements, generally thought to be
hypermethylated as a means to protect the host [23].
The paucity of sequence markers at the highly repetitive
centromeres presents a considerable challenge to the study of
DNA methylation. However, studies in immunodeﬁciency,
chromosome instability, and facial abnormalities (ICF) syn-
drome have given some insight into the role of DNA
methylation in centromere stability. Patients with ICF
syndrome carry a mutation in the DNMT3b gene and lose
the ability to methylate DNA [24]. Owing to a substantial
decrease in DNA methylation at both centromeric [25] and
pericentric sequences [26], the chromosomes of these patients
contain large regions of decondensed pericentromeric heter-
ochromatin, suggesting that normal human centromeres are,
overall, in a hypermethylated state. However, the repetitive-
DNA nature of centromeres has precluded a detailed analysis
of the pattern of methylation at the centromere.
Previously, we identiﬁed and characterized the phenom-
enon of ectopic human centromeres, known as neocentro-
meres [9,27,28]. Human neocentromeres form epigenetically
at euchromatic chromosomal sites and are functionally and
structurally similar to normal human centromeres [1,7,9].
These neocentromeres contain fully deﬁnable sequences and
provide a tractable system for the molecular analysis of
centromeric chromatin [29–31]. Using a neocentromere
formed at band q25 of a Chromosome 10–derived neocentric
marker chromosome mardel(10) (M10), we previously deﬁned
the relative positions of the constitutive centromeric proteins
CENP-A and CENP-H, heterochromatin protein HP1a,
enhanced chromosomal scaffold/matrix attachment regions
(S/MAR), and delayed timing of centromeric DNA replication
[30,32,33]. In addition, we previously showed that the tran-
scriptional activity of genes within the modiﬁed neocentric
chromatin is unaffected [32]. Here we take advantage of the
fully known sequence, together with emerging knowledge
regarding the chromatin organizational and transcriptional
properties of the M10 neocentromere, to investigate the
relationship between DNA methylation and chromatin-
domain distribution and transcriptional competence at a
functional human centromere.
Results
We use the term CpG ‘‘islet’’ to describe a genomic region
that is not classiﬁed as a CpG island because of its shorter
length (,200 bp), but otherwise has a GC content and
observed-to-expected CpG ratio that is characteristic of a
CpG island. This study predominantly utilized two mono-
chromosomal somatic cell hybrid lines, CHO–M10 and CHO–
N10, which carried M10 or the normal paternal progenitor
human Chromosome 10 (N10), from which M10 was derived
[27,32]. To measure DNA methylation, we performed sodium
bisulﬁte PCR and sequencing [34] on CpG islands and CpG
islets selected from M10, and we compared their methylation
pattern to the same islands and islets on N10. At least eight
PCR amplicons were cloned and sequenced from M10 as well
as from N10. The methylation level was expressed as a
percentage of the number of CpG sites methylated to the
total number of CpG sites assayed for each CpG island or islet.
To ensure that any differences in DNA methylation
between M10 and N10 were not an artifact of cell-line
generation and maintenance [35], we used early-passage
clonal lines of M10 and N10 for analysis. In addition, as
controls, we used a number of CpG islands and islets from
chromosomal bands 10p14 and 10q26.2, which were 39 Mbp
and 7 Mbp, respectively, from the 10q25 neocentromere
(Figure 1A). These were presumed to be sufﬁciently distant to
be independent of the chromatin environment of the 10q25
neocentromere. The methylation level of these control CpG
islands ranged from 0%–2% in both M10 and N10 (Figure 1B;
Table S1). In N10, the methylation level of the control CpG
islets ranged between 68% and 95%, while the same CpG
islets in M10 ranged between 75% and 96%. Overall, the
difference in methylation (M10 minus N10) ranged between
 6% and þ8%, reﬂecting background variation of our
analytical system.
To determine the DNA-methylation proﬁle and its relation
to the chromatin environment of the neocentromere, we
identiﬁed 129 GC-rich sequences within a 6.76-Mbp DNA
region spanning the 10q25 neocentromere. In total, 2,041
individual CpG dinucleotides were assayed for DNA methyl-
ation, both before and after neocentromere formation
(Tables S2 and S3). Throughout this study, methylation of
cytosine at non-CpG sites was not observed.
Methylation of CpG Islands
Across the 6.76-Mbp region, a total of 180 CpG islands were
identiﬁed using the classical deﬁnition of a CpG island [15]
(Table 1). Of the 180 islands, 78 were identiﬁed as being
members of repetitive families. The number of CpG islands
across this region was reduced to 20 using the modern CpG
island deﬁnition [22]. This was in keeping with a total number
of 50 annotated genes within this region. The more stringent
criteria excluded all DNA repeats that were identiﬁed by the
classical deﬁnition. For our methylation analysis, we selected
a total of 22 CpG islands, of which six conformed to the
modern criteria (Table 1).
CpG islands selectedfor DNA-methylation analysis ranged in
size from 200 to 2,428 bp. Eleven of these CpG islands showed
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Synopsis
The centromere is a chromosomal structure that is vital for the
correct partitioning of chromosomes during cell division. Recent
studies in a number of different species have shown that
transcription is permissible within the centromere, but the mode
of transcription regulation at the centromere remains unclear. DNA
methylation is a well-characterized mechanism for the genomic
regulation of transcription. Here, the authors investigate the
relationship between DNA methylation and transcription activity
at a functional human centromere. They demonstrate a high level of
DNA methylation across the centromere but identify pockets of DNA
sequences within the methylated domain that are non-methylated.
These pockets correspond to sites of transcription and/or bounda-
ries that separate major centromeric chromatin sub-domains. This
study shows the complexity of the centromere as it uses DNA
methylation to both maintain a tight chromatin structure and to
allow transcription to occur.almost no detectable DNA methylation (0%–3% of sites
methylated) for both N10 and M10 (Figure 2). Five of these
islands were directly associated with the 59 end of genes
FLJ10188, KIAA1600, TRUB1, ATRNL1, and GFRA1 (labeled
1–5, respectively, in Figure 2) that we have previously shown to
be expressed at equal levels on both N10 and M10 [32]. The
remaining 11 islands showed detectable levels of DNA methyl-
ationonN10.Followingneocentromereformation,thelevelsin
ﬁve of these islands were largely unaltered, while three islands
showed a 2%–15% increase in CpG methylation. Taken
together, we observed an overall pre- and post-neocentromere
DNA-methylation level mean of 34.3% and 37.1%, respec-
tively—a difference of 2.8% (p ¼ 0.113, paired t-test)—
demonstrating that the levels of methylation of these CpG
islands were not signiﬁcantly different between N10 and M10.
In contrast, the methylation levels for the ﬁnal three islands
(labeled a–c in Figure 2A and 2D) were signiﬁcantly reduced
from a range of 51.3%–65.2% in N10 to a range of 0%–0.4%
in M10 (p , 0.0001, paired t-test). These three islands were
positioned towards the p9 outer boundary region of the
previously mapped HP1a-binding and S/MAR–enriched
chromatin [32] (Figure 2E).
Figure 1. The 10q25 Locus and Control Regions Used in This Study
(A) Chromosome ideogram representing the derivation of the M10 chromosome containing the neocentromere formed at the 10q25 band. CpG islands
and CpG islets selected from the p14 and q26.2 bands situated 39 and 7 Mbp from the neocentric sites, respectively, were measured for methylation in
both N10 and M10 cell lines.
(B) The level of methylation is shown for the same CpG islands and CpG islets in N10 and M10, and for their differences (M10 minus N10). CpG islands of
.500 bp are represented by black bars; CpG islands of .200 bp and ,500 bp are represented by light-blue bars; and CpG islets are represented by red
bars.
DOI: 10.1371/journal.pgen.0020017.g001
Table 1. CpG Islands across the 6.76-Mbp 10q25 Region Analyzed
Type of CpG Island .200 bp, G þ C . 50%,
Observed/Expected CpG
. 0.6
a
.500 bp, G þ C   55%,
Observed/Expected CpG
. 0.65
b
CpG Islands
Assayed: Classical
a
CpG Islands
Assayed: Modern
b
Unique sequence 80 6 11 4
Simple repeat/low-complexity DNA 22 14 2 2
Alu repeats 69 0 2 0
DNA repeats 9 0 1 0
Total number of CpG islands 180 20 16 6
Simple repeats and low-complexity DNA refer to polynucleotide repeats. All repeats include SINE and MIR elements. DNA repeats include long terminal repeats (LTR) and LINE elements [65].
aClassical definition [15].
bModern definition [22].
DOI: 10.1371/journal.pgen.0020017.t001
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Centromere DNA Methylation and TranscriptionFigure 2. DNA-Methylation Profiles for 129 Separate CpG Islands and Islets
Profiles apply across a 6.76-Mbp DNA section of the 10q25 region before (N10) and after (M10) neocentromere formation. The y-axis shows the
percentage methylation in CHO–N10 and CHO–M10, and the percentage methylation difference (CHO–M10 minus CHO–N10).
(A) Classically defined CpG islands [15] are represented by blue bars, while CpG islands conforming to the modern definition [22] are identified by black
bars. Genes previously shown to be expressed in both CHO–N10 and CHO–M10 and known to be associated with a 59 CpG island are labeled (1)
FLJ10188, (2) KIAA1600, (3) TRUB1, (4) ATRNL1, and (5) GFRA1, with the position of their 59-associated CpG islands indicated by inverted triangles, and
the direction of transcription and the full extent of the two larger genes (4 and 5) indicated by the horizontal arrows and shaded areas, respectively.
(B) CpG islets analyzed in this study with lengths ranging from 100 to 200 bp (green bars) or 50–99 bp (red bars).
(C) Methylation levels of CpG islets identified as retrotransposable and other interspersed repetitive elements analyzed in this study. The full extent of
the two larger genes (4 and 5) is indicated by the shaded areas. The length of CpG islets ranges from 100 to 200 bp (green bars) or 50–99 bp (red bars).
(D) Summary of percentage methylation difference between CHO–M10 and CHO–N10. Three CpG islands and six CpG islets that are hypomethylated in
M10 compared to N10 are denoted by a–i.
(E) Relative positions of previously described chromatin domains corresponding to foundation centromeric proteins CENP-H and CENP-A,
heterochromatin protein HP-1a, and enhanced S/MAR regions [32], and a region of delayed DNA replication [30].
DOI: 10.1371/journal.pgen.0020017.g002
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The failure to detect a signiﬁcant overall methylation
difference within the neocentromere core region, owing to
the conventionally deﬁned CpG islands, prompted us to
examine DNA sequences that we have designated as CpG
islets. We analyzed a total of 107 CpG islets (Figure 2B). A
small number of CpG islets (4/107) showed a low level of
methylation that was not detectably altered in N10 and M10.
Of the remaining CpG islets, 97 had detectable underlying
DNA methylation in N10, with the majority (84/97) showing
increased DNA methylation to saturating levels in M10
(Figure 2B). Twelve CpG islets showing increased methylation
were located within the introns of expressed genes ATRNL1
(eight islets) and GFRA1 (four islets) (genes 4 and 5, Figure 2B
and 2D). Overall, the level of CpG islet-related DNA
methylation within the neocentromere increased from a
pre-neocentromere mean of 61% (in N10) to a signiﬁcantly
higher post-neocentromere value of 83% (in M10)—a differ-
ence of 22% (p , 0.0001, paired t-test).
Not all differentially modiﬁed CpG islets showed an
increased methylation pattern. Six islets, labeled d–i in Figure
2B and 2D, showed a substantial decrease in methylation level
from 64.9% in N10 to 35.9% in M10 (a difference of 29.1%, p
, 0.002, paired t-test). As with the three hypomethylated CpG
islands, these hypomethylated CpG islets resided towards the
outer boundaries of the S/MAR enrichment—CENP-H- and
HP1a-binding domains within the neocentromere (Figure 2E).
Methylation of Interspersed Repeats
Our analysis also investigated the level of DNA methylation
within 25 sequences that were comprised of retrotranspos-
able or other repetitive elements, including LINEs (long
interspersed nuclear elements), SINEs (short interspersed
nuclear elements), and MIRs (mammalian interspersed
repeats) (Figure 2C) (see Tables S2 and S3 for detailed
locations and repeat subtypes). These elements showed
variable levels of DNA methylation on N10; however, upon
neocentromere formation, these levels increased to satura-
tion within the M10 neocentric chromatin (Figure 2C). Four
islets (and one island) within the introns of ATRNL1 (gene 4,
Figure 2A and 2D) and three islets within those of GFRA1
(gene 5, Figure 2A and 2D) belonged to these classes of
interspersed repeats.
Methylation of CpG-Orphan Sites
The observed differences in methylation of CpG islets
prompted us to further assess DNA methylation at CpG
dinucleotides within DNA sequences that were GC-poor
(,40%) and without the expected frequency of CpG
dinucleotides. As such, these sequences were not classiﬁed
as either CpG islands or CpG islets. The CpG dinucleotides
found in these sequences, which we have termed orphaned
CpGs, are thought to be methylated as they reside outside the
realm of CpG islands [14].
We selected 25 regions encompassing 75 CpG orphans
across the 6.76-Mbp neocentromere domain for bisulﬁte PCR
and sequencing (Figure 3; Table S4). Our results showed that
methylation at orphan CpG sites in N10 and M10 were highly
variable. However, within the neocentromere region, a
signiﬁcant number of orphan-containing regions (Ops) (Op-
4, Op-5, Op-7, Op-9, Op-10, Op-11, Op-12, Op-14, Op-15,
and Op-18; Figure 3) showed increased methylation from a
pre-neocentromere (N10) mean of 46% to a post-neocen-
tromere (M10) mean of 78%—a difference of 32% (p ,
0.0001, paired t-test). In addition, we observed hypomethyla-
tion in a small number of Ops (Op-6, Op-8, and Op-19; Figure
Figure 3. Methylation Analysis of CpG Orphans
A total of 75 CpG orphans were selected from 25 sites (Op-1 to Op-25). Red circles denote methylated CpG dinucleotides, and yellow circles denote
unmethylated CpG dinucleotides. The positions of Op-1 to Op-25 sites with respect to the previously defined centromeric chromatin domains (shaded
area) are indicated (refer to Figure 2E for details). Sites showing differential hypermethylation following neocentromere formation are labeled on top.
Sites showing differential hypomethylation are denoted by asterisks. CpG dinucleotides that are putative MeCP2-binding sites are indicated by solid
diamonds. Upon treatment with 5-aza-dC, a number of CpG orphans (Op-4, Op-9, Op-11, Op-12, Op-17, and Op-18) demonstrated a significant decrease
in DNA methylation.
DOI: 10.1371/journal.pgen.0020017.g003
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Centromere DNA Methylation and Transcription3) in M10 compared to N10 that were again located near the
outer boundaries of previously deﬁned neocentric chromatin
domains. These ﬁndings therefore provided corroborating
evidence for the methylation trends observed with the CpG
islets following neocentromere formation in M10.
Maintenance of DNA-Methylation Profile at the
Neocentromere in Different Cell Lines
In order to address the concern that the DNA-methylation
proﬁle we observed might be cell line–speciﬁc, we transferred
the human M10 chromosome into mouse F9 cells and mouse
ES cells, and compared the DNA-methylation level of two
CpG islands, a CpG islet, and three CpG orphans with those
of M10 in the Chinese hamster ovary (CHO) background.
CpG islands 58 and 93 were hypomethylated in M10 in the
CHO background and remained hypomethylated in the
mouse F9 and ES somatic cell hybrid lines (Figure 4). CpG
islet 31 and orphans 14, 17, and 21 were hypermethylated in
M10 in CHO and remained hypermethylated in both mouse
backgrounds. These data indicated that the observed DNA-
methylation patterns were not due to cell-line differences.
Non Strand-Specificity of DNA Methylation at the
Neocentromere
As the nature of bisulﬁte PCR and sequencing is strand-
speciﬁc, we tested the possibility of a strand-speciﬁc bias in
DNA methylation. We assayed methylation of the comple-
mentary ( ) DNA strand on one CpG island and of three CpG
islets that represented either no methylation difference, or
differential hyper- or hypomethylation between M10 and N10
(Figure 5). These sequences corresponded to the unspliced
expressed sequence tags (ESTs) AA811493 and AI024013
(island b and islet g, respectively, Figure 2D) and two
randomly chosen islets (listed as islets 43 and 102 in Tables
S2, S3, and S5). The results indicated that, in all cases, the
overall methylation level for the positive strand was closely
comparable to that of the negative DNA strand (Figure 5A),
suggesting the absence of any strand-speciﬁc bias in DNA-
methylation proﬁle at the 10q25 neocentromere.
EST Expression of Differentially Hypomethylated CpG
Islets
Of the nine CpG islands/islets that showed signiﬁcant DNA
hypomethylation, two corresponded to the unspliced ESTs
AA811493 and AI024013 (island b and islet g, respectively,
Figure 2D), where the DNA-methylation levels decreased
from 59.1% in N10 to 0% in M10 for AA811493, and from
91% in N10 to 9.2% in M10 for AI024013 (Figure 5A).
Analysis of the transcription status of these two ESTs before
and after neocentromere formation using RT-PCR indicated
no basal transcription from both loci in N10, but did indicate
clear transcription in M10 (Figure 5B). The gene TRUB1
(gene 3 in Figure 2A, shown to be expressed in both N10 and
M10 previously [32]), was used along with 18S as a positive-
expression control. The detection of transcriptional activity
was therefore in keeping with the demethylated state of these
two EST-associated CpG island/islets in M10 (Figure 5A).
Reduction of DNA-Methylation Level Using 5-aza-
Deoxycytidine
To ascertain whether CpG methylation is important for the
functional integrity of the neocentromere, we used a DNA
methylation–inhibiting drug, 5-aza-deoxycytidine (5-aza-dC),
to reduce methylation at the neocentromere. Centromere
instability was measured by the appearance of lagging or
bridging chromosomes at anaphase (Figure 6). The cells were
treated with 20 lM 5-aza-dC over a period of 3 d, followed by
synchronization with nocadazole and release in the presence
of cytochalasin B (see Materials and Methods). This treatment
inhibits cytokinesis and can enhance the retention of cells
containing missegregated chromosomes. Following treat-
ment, the proportion of anaphase cells containing bridging
(Figure 6B) or lagging (Figure 6C and 6D) chromosomes
increased from 19% in control PBS-treated cells to 69% in
cells treated with 5-aza-dC (Figure 7A).
No lagging or bridging M10 chromosomes were identiﬁed
amongst 150 PBS-treated anaphase cells examined. However,
when treated with 5-aza-dC, lagging M10 chromosomes were
found in 6% (4/65) of anaphase cells (Figure 6E), suggesting
that disruption of DNA methylation at the M10 neocentro-
Figure 4. Determination of Possible Variation in DNA-Methylation Pattern owing to Cell-Line Differences
The neocentromere-containing M10 chromosome was initially studied in a CHO hybrid cell background but was transferred to a mouse F9 and mouse
ES cell line for further testing. DNA methylation was assessed on a selected number of CpG island, islets, and orphans that showed different DNA-
methylation levels in the initial assay in CHO. The results indicated no significant difference in methylation levels in all three cell backgrounds.
DOI: 10.1371/journal.pgen.0020017.g004
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Four sequences were chosen for this analysis.
(A) The EST-associated CpG island (AA811493; island b in Figure 2A and 2D), the EST-associated CpG islet (AI024013; islet g in Figure 2B and 2D), and
two additional islets designated as numbers 43 and 102, respectively (see Tables S2, S3, and S5). Individual CpG dinucleotides are shown as columns.
Red and yellow circles denote a methylated and unmethylated CpG dinucleotide, respectively. A very small number of undetermined sites are indicated
by white circles. The aligned columns represent the same CpG dinucleotide from both strands. The methylation level was calculated as described in
Materials and Methods.
(B) RT-PCR analysis of an EST-associated CpG island (AA811493) and islet (AI024013). Positive controls were the 18S RNA standard and TRUB1
(corresponding to gene 3 in Figure 2A), which has previously been shown to be expressed in both CHO–N10 and CHO–M10 [32]. RT indicates control
lanes showing no DNA contamination from RNA prepared for this analysis.
DOI: 10.1371/journal.pgen.0020017.g005
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Centromere DNA Methylation and Transcriptionmere perturbed centromere function, causing chromosomal
instability and missegregation.
Immunofluorescence Studies
To investigate whether 5-aza-dC affected chromatin pro-
tein binding, we measured the signal intensity of antibodies
raised against three different heterochromatin markers: 5-
methylated cytosine (5MeC), methylated DNA-binding do-
main (MBD) protein 1, and histone H3 (tri-methylated lysine
9), at the M10 neocentromere. In addition, we included
antibodies against penta-acetyl histone H4 (a marker for
euchromatin) and the constitutive centromeric histone H3
variant, CENP-A. Human CREST-3 antiserum [27] recognizes
all human centromeres and was used to co-detect with the
various antibodies.
Three independent experiments were performed using 20
lM 5-aza-dC. From each experiment, 20 metaphase chromo-
some spreads were digitally captured for ﬂuorescence-
intensity measurement at the M10 neocentromere (Table
S6). The CREST-3 signal was found to be consistent on the
M10 neocentromere before and after 5-aza-dC treatment
within all three experiments (data not shown), and was used
for signal normalization to calculate a ﬂuorescence-intensity
ratio. The ﬂuorescence-intensity ratio was calculated for each
test antibody to the CREST-3 signal at the neocentromere
(Table S7). The mean ﬂuorescence-intensity ratio was used to
compare 5-aza-dC–treated cells to untreated cells. A signiﬁ-
cant decrease in ﬂuorescence-signal ratio was observed for
5MeC after 5-aza-dC treatment (1.5; p , 0.00001; paired t-
test) (Figure 7B), indicating that DNA methylation at the
neocentromere was perturbed. In line with this, signiﬁcant
reductions in ﬂuorescence-signal ratios were seen in the
heterochromatin markers MBD1 (10.2; p ¼ 0.0003; paired t-
test) and 3MeK9H3 (1.5; p ¼ 0.014; paired t-test). No
signiﬁcant change was observed with CENP-A (0.1; p ¼ 0.21)
and the euchromatin marker, penta-acetyl histone H4 (0.5; p
¼ 0.14) (Figure 7B).
CpG Methylation Following 5-aza-dC Treatment
We selected two CpG islands and eight CpG islets from
Figure 2 for bisulﬁte PCR and sequencing after 5-aza-dC
treatment. The CpG islets (numbered 28, 31, 69, 70, 71, 74, 76,
and 101, Figure 7C) showed a signiﬁcant increase in
methylation in M10 when compared to N10 before 5-aza-dC
treatment. Amongst these CpG islets, six (numbered 28, 31,
69, 70, 71, and 101) showed a signiﬁcant reduction in
methylation (with the reduction ranging between 14.5%
and 68.1%) after 5-aza-dC treatment. In comparison, meth-
ylation of the remaining two CpG islets in this group
(numbered 74 and 76, Figure 7C) was not altered signiﬁcantly
after 5-aza-dC treatment.
CpG islands 93 and 116 showed hypomethylation in M10
compared to N10 before 5-aza-dC treatment, and remained
hypomethylated after addition of 5-aza-dC (Figure 7C).
In addition, we used bisulﬁte sequencing analysis to
determine the methylation status of the CpG dinucleotides
within the 25 sites containing CpG orphans following 5-aza-
dC treatment (Figure 3). Of the ten sites (Op-4, Op-5, Op-7,
Op-9, Op-10, Op-11, Op-12, Op-14, Op-15, and Op-18) that
were hypermethylated in M10 before drug treatment, ﬁve
(Op-4, Op-9, Op-11, Op-12, and Op-18) showed a signiﬁcant
reduction in methylation level in one or more CpG
dinucleotides (Figure 3). No signiﬁcant change was seen in
M10 for the remaining orphans before and after drug
treatment.
Distribution of Putative MeCP2 Sites at the 10q25
Neocentromere
In the light of a recent study identifying the binding-
sequence requirement of the MBD protein MeCP2 [36], we
examined the distribution of putative MeCP2-binding sites in
all the CpG islands, CpG islets, and CpG orphans analyzed in
this study. A large proportion of CpG dinucleotides in the
CpG-orphan regions (49.3% of CpGs analyzed) were found to
be putative MeCP2-binding sites (Table 2 and Figure 3). In
contrast, the proportions of putative MeCP2-binding sites
associated with the CpG islands and CpG islets were
signiﬁcantly lower (4.7% and 10.7%, respectively, Table 2).
These ﬁndings suggest that the CpG-orphan regions may
provide a potentially very rich genomic repertoire for MeCP2
binding and its associated activities.
Discussion
Bisulﬁte PCR and sequencing provides a sensitive techni-
que to measure DNA methylation quantitatively at every CpG
dinucleotide within a genomic region of interest [34]. Here,
we used this technique to study DNA methylation over a 6.76-
Mbp DNA region at the 10q25 locus of the normal human
chromosome N10 and the M10 derivative.
As a control, we measured DNA methylation of seven
sequences that are positioned at a considerable distance (.7
Mbp) from the neocentromere domain (Figure 1) to
determine whether the process of generating the N10 and
M10 CHO cell lines had affected DNA methylation. No
signiﬁcant difference was observed in the methylation of
these sequences between N10 and M10, suggesting that the
generation of these cell lines has not altered the pattern of
DNA methylation. Furthermore, we directly compared the
DNA-methylation levels of a number of CpG islands, islets,
and orphans within the M10 neocentromere in CHO and two
mouse cell lines. We found no signiﬁcant differences,
indicating that the DNA-methylation patterns we observed
in this study were not caused by cell-line differences. We also
investigated the phenomenon of strand-biased methylation
previously reported in Arabidopsis centromeres [37]. Our
results indicate no signiﬁcant strand-biased methylation in
any of the CpG island/islet examples assayed at the neo-
centromere. These results are consistent with the observed
activity of the vertebrate housekeeping DNMT1 that converts
hemi-methylated CpG dinucleotides to a fully methylated
state [10]. A previous study in plants also demonstrated
methylation of the cytosine residue of CpNpG trinucleotides
by chromomethylase [38]. To date, such methyltransferases
have not been identiﬁed in vertebrates [10], and this is
consistent with the fact that no methylation of CpNpG
trinucleotides (or any other non-CpG sites) was observed
throughout our study.
In all, we analyzed the methylation status of 2,041 CpG
dinucleotides distributed amongst CpG-island, -islet, and -
orphan sequences within the 10q25 region. We found a
substantial increase in the overall level of DNA methylation at
the neocentromere compared to its pre-centromere state at
normal 10q25. It is not possible to extrapolate from these
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responsible for the epigenetic formation of a functional
neocentromere, as it is possible that the observed changes in
DNA methylation occur subsequent to neocentromere seed-
ing. However, the observed increase in DNA methylation at
the neocentromere could provide the basis for the epigenetic
identity and maintenance of the centromere [4]. Other
studies have shown, for example, that while chromatin
remodeling involving histone modiﬁcations precedes the
silencing of genes during mammalian X-inactivation, the
inactive status is imprinted and maintained through DNA
methylation (reviewed in [39] and in references listed there-
in).
DNA hypermethylation at the neocentromere is shown to
occur throughout the previously mapped functional chroma-
tin domains of enhanced S/MAR, and CENP-H, CENP-A, and
HP1a-binding [32]. Our data demonstrate that this hyper-
methylation is attributed primarily to the systemic methyl-
ation of the CpG islets and CpG orphans, but not the
conventional CpG islands. Several studies have shown that
CpG methylation promotes the recruitment of silencing or
heterochromatin protein complexes and the assembly of a
compacted chromatin state [40–42]. A number of such
protein complexes, including the methylated CpG-binding
proteins MBD1, MBD2, and MeCP2, plus DNMT1, DNMT3b,
and heterochromatin protein HP1a, have been observed on
the M10 neocentromere [5]. It is possible that the hyper-
methylation seen at the neocentromere serves to recruit these
protein complexes to impart and maintain an overall
compact centromeric chromatin state.
Figure 7. Effects of 20 lM 5-aza-dC Treatment on the 10q25 Neocentromere
(A) Inhibition of DNA methylation with 5-aza-dC increases centromere instability as demonstrated by a significant increase in the proportion of
anaphase cells containing lagging or bridging chromosomes when compared with non-drug-treated PBS control Asterisk indicates p , 0.001, v
2-test.
(B) Fluorescence-intensity ratio of chromatin proteins at the M10 neocentromere before and after 5-aza-dC treatment. The amount of 5MeC and MBD1,
indicators of DNA methylation, was significantly reduced at the 10q25 neocentromere after 5-aza-dC. The histone modification, 3MeK9H3, associated
with methylated DNA, also showed a significant reduction after 5-aza-dC treatment. Penta-acetylated H4, a histone modification associated with
euchromatin, and constitutive centromeric protein A (CENP-A) were not significantly altered after 5-aza-dC treatment (mean raw fluorescence values are
presented in Table S6). Single asterisk denotes p¼0.014, and double asterisks denote p , 0.001 in a Fisher’s Exact t-test, with error bars representing
standard errors of the mean.
(C) Determination of DNA-methylation level of eight CpG islets and two islands at the 10q25 neocentromere following 5-aza-dC treatment. Six CpG
islets (28, 31, 69, 70, 71, and 101) showed an increase in DNA methylation upon the formation of the 10q25 neocentromere. However, following 5-aza-
dC treatment, the methylation level of these CpG islets decreased significantly. The locations of the eight CpG islets and two CpG islands (numbers 93
and 116) with respect to the mapped centromere domains are depicted on the scale bar. The numbers for the CpG islands and islets correspond to
those shown in Tables S2, S3, and S5.
DOI: 10.1371/journal.pgen.0020017.g007
Figure 6. Anaphase Analysis of CHO–M10
Cells were treated with 20 lM 5-aza-dC for a period of 3 d.
(A) An untreated control cell undergoing normal anaphase, hybridized with M10-specific FISH probe to show correctly segregated M10 neocentromere
(blue-green, filled arrowheads).
(B and C) 5-aza-dC–treated anaphase cells showing lagging or bridging chromosome (open arrowhead) and the location of the correctly segregated
M10 neocentromeres (green, filled arrowheads).
(D) Anaphase cell with multiple lagging chromosomes (open arrowheads) and correctly segregated M10 (green, filled arrowheads).
(E) Anaphase cell with a lagging M10 chromosome (open arrowhead). The M10 neocentromere probe is shown in green (filled arrowhead). Scale bar
denotes 5 lm.
DOI: 10.1371/journal.pgen.0020017.g006
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uniformly hypermethylated. We identiﬁed at least two
situations in which hypomethylation of pockets of centro-
meric DNA occurs. Firstly, we observed a distinct clustering
of hypomethylated sites at the p9 and q9 outermost regions of
the mapped S/MAR–enhanced and CENP-H–binding do-
mains. Two discernible sites of hypomethylation also coincide
with the HP1a-binding domain and the inner boundary of
the CENP-H-binding (or S/MAR–enhanced) domain. It is
possible that DNA hypomethylation marks the site of
transition between two different centromeric chromatin
domains, such as through the recruitment of insulator
proteins to demarcate and protect a chromatin domain from
the disruptive spreading of dissimilar neighboring chromatin
states [43]. Our demonstration of transcriptional activity at
two of the hypomethylated boundary sites (island b and islet
g) further suggests that hypomethylation of the boundary
regions may be important for the transcription of centro-
meric DNA in these regions (see below), and that CpG islets,
like CpG islands, could play a role in the expression-control
of genes and ESTs.
The second situation in which we observed subregional
hypomethylation of centromeric DNA relates to the sites of
transcriptional activity. We identiﬁed seven transcriptionally
active sites within the 6.76-Mbp region studied. As discussed
above, two of these sites correspond to the unspliced ESTs
AA811493 and AI024013 that are found at the outer
boundary of the centromeric chromatin (island b and islet
g, respectively). The remaining ﬁve sites are associated with
the expressed genes FLJ10188, KIAA1600, TRUB1, ATRNL1,
and GFRA1 (genes 1–5 in Figure 2D) that are located within
the S/MAR–enriched region, including a gene (gene 4) that
spans across the CENP-A–binding domain. We showed that
all seven expressed loci are associated with hypomethylated
sites.
Given the prevalence of hypermethylation in the M10 over
the N10 background, it could be intuitively expected that
some of the genes embedded in the neocentric chromatin
would have undergone silencing. This, however, is not the
case, as we have previously demonstrated that all 51 known
genes within or near the neocentric chromatin showed the
same expression proﬁle in both the M10 and N10 cell lines
[32], regardless of whether the genes are expressed or
silenced. However, in that study, we did not investigate the
relative expression properties of the many annotated ESTs
not characterized as genes. Whether some of these ESTs are
differentially hypermethylated and therefore silenced follow-
ing neocentromere formation remains unclear. In this regard,
some of the expressed genes within this region [32] do not
have a corresponding CpG island. Whether the transcrip-
tional regulation of these genes occurs through the methyl-
ation of CpG islets or CpG orphans remains to be
determined.
Previous studies have shown that ICF-syndrome patients
with a mutation of the DNMT3b gene show centromeric and
pericentric chromatin decondensation [26,44], and the
possible re-enactment of this phenotype in cells treated with
the methylation inhibitor, 5-aza-dC [45]. We investigated the
functional signiﬁcance of DNA hypermethylation at the
neocentromere using 5-aza-dC and observed increased
anaphase lagging or bridging of chromosomes, indicative of
centromere instability caused by 5-aza-dC–induced inhibi-
tion of DNA methylation. Speciﬁcally, we observed anaphase
defects involving the neocentromere-containing M10 chro-
mosome, suggesting neocentromere stability is compromised
by the perturbation of DNA methylation.
Immunoﬂuorescence analysis on the 10q25 neocentromere
showed a signiﬁcant decrease in the level of 5MeC and in the
levels of the methyl DNA-binding and heterochromatin
markers MBD1 and tri-MeK9H3 after 5-aza-dC treatment,
suggesting a direct correlation between DNA methylation
and the binding of these proteins at the neocentromere. The
levels of the constitutive centromeric protein CENP-A, an
essential protein for active centromeres [46,47] and the
euchromatin marker 5-AcH4 were unaffected by 5-aza-dC
treatment. Importantly, we observed a signiﬁcant reduction
of neocentromere-associated methylation in the majority of
the CpG islets and orphans selected for further analysis in the
presence of 5-aza-dC. Taken together, the results obtained
with 5-aza-dC treatment indicate that DNA hypermethylation
is important for the functional integrity of the neocentro-
mere. However, as 5-aza-dC is likely to affect the expression
proﬁle of many proteins, including those involved in the
assembly and modiﬁcation of the centromere, the contribu-
tion of such a generalized genomic effect to centromere
instability following drug treatment remains unclear.
Klose et al. [36] recently described the DNA-binding motif
for MeCP2 as one of CG[A/T]4, CGn[A/T]4, CGnn[A/T]4,
CGnnn[A/T]4, or CGnnnn[A/T]4 (n denotes any base). We
performed in silico analysis of the distribution of CG[n]0–4[A/
T]4 motifs in relation to the 2,041 CpG dinucleotides studied
here (Table 2). We found that a large proportion (49.3%) of
the CpG-orphan sites analyzed in this study contained a
potential MeCP2-binding site when compared to the CpG
islets (10.7%) and CpG islands (4.7%). The ﬁnding of a
relatively greater prevalence of CG[n]0–4[A/T]4 motifs
amongst the CpG orphans compared to the islands is not
unexpected as these sequences are, by deﬁnition, more AT-
rich. Other studies have indicated that chromatin-modiﬁca-
tion proteins including MeCP2 [36,48], CXXC CGBP protein
[49], and MBD1 [50] can bind to a single methylated CpG
dinucleotide, supporting the possibility that orphaned CpG
Table 2. Relative Distribution of Potential MeCP2-Binding Sites
Flanking the CpG Islands, CpG Islets, and CpG Orphans Analyzed
in This Study
Item Total Counts
(Percentage of Total
CpG Dinucleotide Count)
CpG islands analyzed 22
Total CpG dinucleotide count 615
MeCP2-binding sites CG[n]0–4[A/T]4 29
a (4.7%)
b
CpG islets analyzed 107
Total CpG dinucleotide count 1351
MeCP2-binding sites CG[n]0–4[A/T]4 144
a (10.7%)
b
CpG-orphan regions analyzed 25
Total CpG dinucleotide count 75
MeCP2-binding sites CG[n]0–4[A/T]4 38
a (49.3%)
b
MeCP2-recognition sequences were defined as CG[n]0–4[A/T]4, where n could be any nucleotide [36].
aTotal number of sites conforming to the putative MeCP2-binding sequences as determined by Fuzznuc.
bProportion of CpG dinucleotides that are a potential MeCP2-binding site.
DOI: 10.1371/journal.pgen.0020017.t002
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and/or maintenance. In our system, we observed a number of
differentially methylated sites upon neocentromere forma-
tion that are also potential MeCP2-binding sites that could
reﬂect a differential binding of MeCP2 in both states (Figure
3). However, it remains to be empirically determined which
and how many of the CG[n]0–4[A/T]4 motifs found in the CpG
islands, islets, and orphans at the neocentromere are directly
involved in MeCP2 binding.
We performed further in silico analysis on the relative
distribution of individual CpG dinucleotides within the 6.76-
Mbp 10q25 region under study. The results indicate that only
3.5% (2,496/70,502) are associated with CpG islands [15,51],
with the remaining 14% (10,006/70,502) and 82.5% (58,000/
70,502) being present as islets and orphans, respectively. Such
a distribution pattern closely reﬂects that of a genome-wide
calculation of CpG dinucleotide composition: CpG islands
(8.32%), CpG islets (5.88%), and CpG orphans (85.79%)
(Table 3). This analysis reveals that CpG islets and orphaned
CpG dinucleotides together constitute by far the bulk of the
human genomic CpG dinucleotide pool. Our study showed
that changes to the methylation status of islets and orphans
are associated with the gain or loss of heterochromatic or
transcriptional state. These ﬁndings suggest that differential
methylation of the genomically abundant and widely dis-
tributed repertoire of CpG islets and orphaned dinucleotides,
in conjunction with the more widely studied CpG islands,
may provide a more encompassing mechanism of genomic
control of chromatin and transcriptional status than a
mechanism based solely on the CpG islands.
The centromere has long been thought to be heterochro-
matic and transcriptionally silent. However, more recent
studies in Arabidopsis, rice, maize, mice, and humans have
demonstrated that transcription can occur within the
centromere, suggesting that centromeres are not entirely
heterochromatic [32,52–57]. Studies in humans, Drosophila,
Schizosaccharomyces pombe, and rice have further shown that
histone modiﬁcations that are associated with both euchro-
matin and heterochromatin have been found to be associated
with the centromere [58–60]. DNA methylation provides an
important marker for heterochromatin and is a mechanism
for transcriptional regulation, but the detailed pattern of
DNA methylation at the centromere has remained poorly
understood, mainly reﬂecting the difﬁculty associated with
the study of conventional, repetitive DNA-based centro-
meres. We overcame this difﬁculty using a neocentromere,
the sequence of which is fully deﬁned and does not contain
tandemly repetitive DNA sequences. We showed that the
DNA of a functional centromere is maintained in an overall
hypermethylated state, consistent with the general hetero-
chromatic and transcriptionally ‘‘silent’’ characteristics of
this structure. Importantly, we demonstrated that pockets of
hypomethylation within the centromere provide the neces-
sary chromatin environment to allow transcription to take
place without compromising the overall ‘‘heterochromatic’’
state and function of the centromere. In addition to
transcription sanctioning, the observed clustering of hypo-
methylated pockets at the boundaries of a number of
centromeric chromatin domains suggests that DNA hypome-
thylation may serve other important, as yet undeﬁned, roles
at these boundary regions.
Table 3. Genome-Wide Distribution of CG Dinucleotides within CpG Islands as Defined by [15], and within CpG Islets and CpG Orphans
as Defined in This Study
Human Chromosome Total CpG CpG Islands CpG Islands (%) CpG Islets CpG Islets (%) CpG Orphans CpG Orphans (%)
chr1 2,256,627 183,495 8.13 133,193 5.90 1,939,939 85.97
chr2 2,151,936 437,416 20.33 112,743 5.24 1,601,777 74.43
chr3 1,620,941 88,686 5.47 83,194 5.13 1,449,061 89.40
chr4 1,461,443 80,262 5.49 78,642 5.38 1,302,539 89.13
chr5 1,507,615 95,117 6.31 81,620 5.41 1,330,878 88.28
chr6 1,473,327 92,482 6.28 85,495 5.80 1,295,350 87.92
chr7 1,554,596 110,113 7.08 94,654 6.09 1,349,829 86.83
chr8 1,305,015 84,894 6.51 70,698 5.42 1,149,423 88.08
chr9 1,204,230 92,875 7.71 74,440 6.18 1,036,915 86.11
chr10 1,353,534 94,927 7.01 72,787 5.38 1,185,820 87.61
chr11 1,290,095 102,743 7.96 73,911 5.73 1,113,441 86.31
chr12 1,273,993 83,346 6.54 80,003 6.28 1,110,644 87.18
chr13 802,544 45,421 5.66 45,955 5.73 711,168 88.61
chr14 859,806 62,653 7.29 49,532 5.76 747,621 86.95
chr15 869,362 67,028 7.71 49,045 5.64 753,289 86.65
chr16 1,097,776 106,158 9.67 75,815 6.91 915,803 83.42
chr17 1,554,105 124,842 8.03 88,537 5.70 1,340,726 86.27
chr18 677,210 43,857 6.48 36,429 5.38 596,924 88.14
chr19 1,057,112 153,804 14.55 97,242 9.20 806,066 76.25
chr20 717,673 61,937 8.63 42,611 5.94 613,125 85.43
chr21 371,971 25,710 6.91 25,037 6.73 321,224 86.36
chr22 574,647 57,548 10.01 43,164 7.51 473,935 82.47
chrX 1,232,721 64,935 5.27 67,260 5.46 1,100,526 89.28
chrY 205,711 9,323 4.53 13,325 7.87 183,063 88.99
Total 28,474,429 2,369,572 8.32 1,675,358 5.88 24,429,499 85.79
The locations of all the sequences annotated in this table and readable by Genome Browser (http://genome.ucsc.edu) are presented in Table S9.
DOI: 10.1371/journal.pgen.0020017.t003
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Cell culture and genomic DNA isolation. The two monochromo-
somal somatic cell hybrid lines utilized in the study, CHO–M10 and
CHO–N10, carried M10 or the N10 from which M10 was derived,
respectively [32]. Two additional cell lines, containing M10 and
derived from mouse F9 and mouse ES cells, were also used in this
study [32]. Genomic DNA from these cell lines was isolated using
standard phenol/chloroform extraction and ethanol-precipitation
procedures. DNA methylation was inhibited by using the methylation
inhibitor 5-aza-dC. 5-aza-dC was dissolved in PBS and added to the
cell lines at a ﬁnal concentration of 20 lM. The cell lines were
cultured in the presence of the drug over a period of three
consecutive days with daily 5-aza-dC–containing media change.
Sodium bisulﬁte sequencing. The DNA sequence of the 10q25 locus
was obtained from the UCSC Genome Browser (http://genome.ucsc.
edu). CpG islands and CpG islets were selected using CpGReport
(http://www.ebi.ac.uk/emboss/cpgplot) with previously described cri-
teria [15]. CpG orphans were selected as regions of DNA with an
average GC content of less than 40%. Genomic DNA isolated from
CHO–N10 and CHO–M10 was treated with sodium bisulﬁte [34] or
the MethylEasy Kit (Human Genetic Signatures, http://www.
geneticsignatures.com). For each sequence assayed, hemi-nested
primer sets (Tables S2–S4 and S8) were designed to selectively
amplify the fully converted genomic DNA templates after two rounds
of PCR. PCR of each methylation site was performed in triplicate and
then pooled for cloning into pGEMT-Easy vector (Promega, Madison,
Wisconsin, United States). PCR cycling conditions were as follows:
denaturation at 95 8C for 3 min, followed by ﬁve cycles at 95 8C for 10
s, annealing at 2 8C lower than calculated primer Tm [61] for 10 s, and
extension at 72 8C for 2 min, followed by 20 cycles at 5 8C for 10 s,
annealing at 2 8C lower than calculated primer Tm for 10 s, and
extension at 72 8C for 1.5 min. Six to eight clones from each genomic
DNA template were sequenced to determine the methylation status.
The level of methylation was measured as a percentage of methylated
sites to the total number of sites assayed for each sequence. Bisulﬁte
proﬁles for the DNA sequences assayed can be found in Tables S1–S3.
RT-PCR analysis of ESTs. Two independent RNA isolations were
prepared from CHO–N10 and CHO–M10 cell lines using TriZol
Reagent (Invitrogen, Carlsbad, California, United States). Isolated
RNA was treated with Turbo RNase-Free DNase (Ambion, Austin,
Texas, United States) to remove contaminating genomic DNA. cDNA
was synthesized by PCR from 2 lg of total RNA using TaqMan Gold
cDNA Synthesis Kit (Applied Biosystems, Foster City, California,
United States) using primers to ESTs AA811493 (1F—
TTCCCTTTTATTGGAGCTAGG, 1R—AGGTCGTTAAAGATTTCC
CC) and AI024013 (1F—AAAGACAACGAAAGACTTGG, 1R—
CTCTTTCCAATGTGACAAGG), with TRUB1 (1F—AGCCCGAG
GAGTTCTGGTTGTT, 1R—TTTCCCCAGTTCTCCAATGGC) [32]
and 18S RNA standards (Ambion) as positive-expression controls.
PCR conditions were 40 cycles of denaturation at 95 8C for 10 s and
annealing/extension at 55 8C for 10 s.
Immunoﬂuorescence. Immunoﬂuorescence was performed as
previously described [62] using antibodies raised against tri-methyl
lysine 9 modiﬁcation of histone H3 [63], MBD1 [50], 5MeC (Fitzgerald
Industries International, http://www.ﬁtzgerald-ﬁi.com), CENP-A [64],
and penta-acetylated histone H4 (Serotec Laboratories, http://www.
serotec.com). Texas Red–conjugated ﬂuorescent secondary anti-
bodies (Jackson Laboratories, Bar Harbor, Maine, United States)
were used to visualize the primary antibodies. Human anti-serum
from a CREST-syndrome patient [27] and an FITC-conjugated
ﬂuorescent secondary antibody were used to co-detect and identify
the M10 neocentromere. Images were digitally captured using a Zeiss
Axioplan II ﬂuorescence microscope (http://www.zeiss.com) with a
CCD camera connected to a computer running IP-Lab v3.6.5a
software (Scanalytics, http://www.scanalytics.com). Exposure settings
were determined qualitatively to ensure that ﬂuorescent signals were
not saturated, and were used to capture all images from three
independent experiments. The ﬂuorescence signal was measured on
CHO–M10 cells treated with 20 lM 5-aza-dC and was compared with
the signal from CHO–M10 cells, grown without 5-aza-dC, using IP-
Lab v3.6.5a (Table S6). Fluorescent-signal intensity from each
antibody was then expressed as a ratio to the ﬂuorescent-signal
intensity of the CREST-3 antiserum (Table S7).
Anaphase analysis. The M10 cell line was grown on poly-lysine
slides immersed in HAM’s media supplemented with 10% FCS. The
cells were grown in the presence of 5-aza-dC over a period of 3 d, and
were synchronized on the ﬁnal day with 100nM nocodazole (Sigma-
Aldrich, St. Louis, Missouri, United States) for 16 h. The cells were
released from the mitotic block with three rinses in HAM’s media
supplemented with 10% FCS. Cells were then grown in HAM’s media
supplemented with 10% FCS and 10 lM cytochalasin B (Sigma-
Aldrich) for 1 h before being ﬁxed with ice-cold methanol and acetic
acid (3:1). The slides were subjected to ﬂuorescence in situ hybrid-
ization (FISH) using a biotin-labeled BAC probe RP11-153g5 for the
M10 neocentromere. The DNA probe was visualized using FITC-
conjugated avidin as outlined [62]. Slides were mounted in
Vectorshield (Vector Laboratories, http://www.vectorlabs.com) and
images were captured as described above.
In silico analysis of 10q25 neocentromere region. CpGislands,CpG
islets, and CpG orphans analyzed in the current study were annotated
in the appropriate format for the UCSC Genome Browser (http://
genome.ucsc.edu). Sequence analysis was performed using EMBOSS
(http://emboss.sourceforge.net). DNA-sequence data were retrieved
fromthe May 2004 (hg17) referencesequence from the UCSCGenome
Browser, and were uploaded as custom annotation tracks (Table S9).
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(P45973), CXXC CGBP (Q9P0U4), DNMT1 (P26358), DNMT3b
(Q9UBC3), MBD1 (Q9UIS9), MBD2 (Q9UBB5), MeCP2 (P51608),
and penta-acetyl histone H4 (P62805).
The OMIM (http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?db¼OMIM) accession number for ICF syndrome is MIM242860.
The GenBank (http://www.ncbi.nlm.nih.gov/Genbank) accession
number for the tri-methylated lysine 9 of histone H3 is AF531308.
The Celera (http://www.celera.com) accession numbers for the
genes discussed in this paper are FLJ10188 (hCG1781461), KIAA1600
(hCG40995), TRUB1 (hCG40949), ATRNL1 (KIAA0534/hCG39837),
and GFRA1 (hCG40963).
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